Parkwalk closes Xerion investment

We are pleased to announce that the University of Oxford Isis Fund II has made an investment in Xerion, a nanoparticle company spun-out of the University with a novel treatment for cancer. Xerion seeks to commercialise Dr Helen Townley’s… Read More